Similar articles for PMID: 9585004

Year	Number of Results
1919	1
1963	3
1964	1
1965	2
1967	2
1968	1
1971	1
1972	3
1975	1
1977	1
1978	2
1980	5
1981	4
1982	4
1983	3
1984	6
1985	6
1986	2
1987	7
1988	2
1989	8
1990	7
1991	9
1992	3
1993	8
1994	3
1995	7
1996	7
1997	9
1998	21
1999	9
2000	10
2001	8
2002	7
2003	8
2004	4
2005	5
2006	7
2007	5
2008	5
2009	8
2010	1
2011	1
2012	5
2013	3
2014	3
2015	5
2016	2
2017	2
2020	3
2021	3
2022	3
2023	2
2024	0

1

Assessment of whole body L-leucine oxidation by noninvasive L-[1-13C]leucine breath tests: a reappraisal in patients with maple syrup urine disease, obligate heterozygotes, and healthy subjects.

Schadewaldt P, Bodner A, Brösicke H, Hammen HW, Wendel U. Schadewaldt P, et al. Pediatr Res. 1998 May;43(5):592-600. doi: 10.1203/00006450-199805000-00006. Pediatr Res. 1998. PMID: 9585004

2

Practical methods to estimate whole body leucine oxidation in maple syrup urine disease.

Elsas LJ, Ellerine NP, Klein PD. Elsas LJ, et al. Pediatr Res. 1993 May;33(5):445-51. doi: 10.1203/00006450-199305000-00005. Pediatr Res. 1993. PMID: 8511017

3

Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.

Schadewaldt P, Bodner-Leidecker A, Hammen HW, Wendel U. Schadewaldt P, et al. Pediatr Res. 2001 May;49(5):627-35. doi: 10.1203/00006450-200105000-00004. Pediatr Res. 2001. PMID: 11328944

4

Domino liver transplantation in maple syrup urine disease.

Khanna A, Hart M, Nyhan WL, Hassanein T, Panyard-Davis J, Barshop BA. Khanna A, et al. Liver Transpl. 2006 May;12(5):876-82. doi: 10.1002/lt.20744. Liver Transpl. 2006. PMID: 16628687 Free article.

5

Protein and leucine metabolism in maple syrup urine disease.

Thompson GN, Bresson JL, Pacy PJ, Bonnefont JP, Walter JH, Leonard JV, Saudubray JM, Halliday D. Thompson GN, et al. Am J Physiol. 1990 Apr;258(4 Pt 1):E654-60. doi: 10.1152/ajpendo.1990.258.4.E654. Am J Physiol. 1990. PMID: 2185648

6

Glucose and alanine metabolism in children with maple syrup urine disease.

Haymond MW, Ben-Galim E, Strobel KE. Haymond MW, et al. J Clin Invest. 1978 Aug;62(2):398-405. doi: 10.1172/JCI109141. J Clin Invest. 1978. PMID: 670400 Free PMC article.

7

Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.

Riazi R, Rafii M, Clarke JT, Wykes LJ, Ball RO, Pencharz PB. Riazi R, et al. Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E142-9. doi: 10.1152/ajpendo.00431.2003. Epub 2004 Feb 17. Am J Physiol Endocrinol Metab. 2004. PMID: 14970005 Free article. Clinical Trial.

8

Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.

Schadewaldt P, Dalle-Feste C, Langenbeck U, Wendel U. Schadewaldt P, et al. Pediatr Res. 1991 Nov;30(5):430-4. doi: 10.1203/00006450-199111000-00007. Pediatr Res. 1991. PMID: 1754297

9

Application of a [13CO2] breath test to study short-term amino acid catabolism during the postprandial phase of a meal.

Bujko J, Schreurs VV, Nolles JA, Verreijen AM, Koopmanschap RE, Verstegen MW. Bujko J, et al. Br J Nutr. 2007 May;97(5):891-7. doi: 10.1017/S0007114507433049. Br J Nutr. 2007. PMID: 17381966

10

Gender affects 13C-ketoisocaproic acid breath test.

Candelli M, Armuzzi A, Miele L, Nista EC, Pignataro G, Zileri Dal Verme L, Grieco A, Gasbarrini G, Gasbarrini A. Candelli M, et al. Eur Rev Med Pharmacol Sci. 2007 Nov-Dec;11(6):401-6. Eur Rev Med Pharmacol Sci. 2007. PMID: 18306908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

240 results

Results by year